SOXL Direxion 3X ETF: 5 Price Signals After 14% Drop - Thursday Predicted Opening Price? 📉
1 extracted signal · 0 resolved · 1 still active
StockInvest.usIndependent analyst profile- Source published
- 23 Sept 2026, 23:41 UTC
- Recorded by Tahlil Plus
- 24 Sept 2026, 03:49 UTC
AI-generated source summary
The SOXL ETF exhibits a bearish short-term trend with key support at $136.81 and resistance at $165.28. The current price of $146.25 is approaching the support level, and a break below it could signal further downside. A sell signal was triggered from a pivot top found one day ago, suggesting potential for continued decline. The 3-month MACD indicates a buy signal, but it is overshadowed by the dominant bearish trend and negative longer-term outlook. The ETF's high daily movements and recent decline from a pivot top, coupled with decreased volume, suggest increased risk. A suggested stop-loss is set at $138.84, with a further potential target at $134.19. The longer-term analysis points to a potential decline of -39.77% to -87.47% over the next 12 months. The overall outlook remains bearish, with a 'Hold/Accumulate' rating due to observed weaknesses despite some positive short-term signals.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.